MENU
SKYE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Skye Bioscience (SKYE) Ownership - Who owns Skye Bioscience?

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.65M
P/E Ratio
3.57
Total Cash
35.31M
Projected Growth
N/A
Total Debt
321.85K
Revenue
N/A
Risk (Beta)
6.05
Dividend Yield
N/A
Total Cash/Share
1.10
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SKYE
Capitalization
25.6M
P/E Ratio
3.57
Risk (Beta)
6.05
Dividend Yield
N/A
Total Cash
35.3M
Total Cash/Share
1.10
Total Debt
322K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
32.8M
P/B Ratio
0.78
Cash Flow
N/A
Earnings
-1.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
4.77
Current Revenue Per Employee
23699.00
Dividends Per Share - Security
N/A
EBITDA
-50.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.69
Revenue To Assets
-83.39
Shares Held By Institutions
81.7M
Shares Outstanding - Current
32.1M
Total Liabilities
8.49M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-71.731
View a ticker or compare two or three
SKYE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details